Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ).
Fisher & Paykel Healthcare has disclosed a change in the relevant interests of senior executive Justin Peter Callahan, its Vice President of Sales & Marketing, under New Zealand continuous disclosure rules. Callahan acquired 145 ordinary shares on 5 January 2026 at NZ$32.1985 per share through participation in the company’s Employee Stock Purchase Plan, bringing his direct holding to 200,738 ordinary shares, alongside 103,960 options and 64,091 performance share rights, underscoring continued alignment of executive incentives with shareholder interests and the company’s long-term performance.
More about Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited is a New Zealand–listed medical technology company that develops and manufactures products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnoea, serving hospitals and homecare markets globally.
For detailed information about FSPKF stock, go to TipRanks’ Stock Analysis page.